Hospital of Pittsburgh of UPMC
The SRTR, which manages and analyzes a wide range of transplant data as a service to the public, noted several achievements for Children’s in 2017. When comparing hazard ratio estimates, Children’s ranks as number one out of 62 pediatric liver transplant centers in the U.S. in one-year overall patient survival as well as one-year overall graft survival.
Of the 29 centers performing pediatric living-donor liver transplants in the U.S., Children’s hazard ratio estimates also rank first in one-year patient and graft survival, as well as three-year patient and graft survival. Children’s has performed over 135 livingdonor liver transplants since 1997, and more than any pediatric transplant center in the last five years nationally.
The hazard ratio provides an estimate on how the results at Children’s Hospital of Pittsburgh compares with what was expected based on modeling the transplant outcomes from all U.S. programs. Based on the characteristics of patients transplanted at Children’s from July 2013 through December 2015, SRTR hazard ratio results indicate a 59 percent estimated lower risk of patient mortality and a 76 percent estimated lower risk of graft failure when compared to other pediatric liver transplant centers.
“This new data exemplifies the extraordinary talent and skill our surgeons, hepatologists and entire transplant team bring to hopeful patients and families around the world,” said George Mazariegos, M.D., chief of pediatric transplantation at Children’s. “Our decades of experience are unparalleled – we have performed more pediatric liver transplants than any other center in the United States while achieving patient survival rates that are consistently among the best.”
Children’s has performed more than 1,800 pediatric liver transplants since the program’s inception in 1981 through December 2016. This includes:
Liver transplantation is often a lifesaving procedure for children with end stage liver disease, but it’s also an attractive approach for improving quality of life for many young patients with metabolic disease. In 2004, the protocol for liver transplantation for Maple Syrup Urine Disease (MSUD) was developed at Children’s Hospital of Pittsburgh. Today, these patients show normal liver function, have avoided the risk of neurological complications and enjoy an unrestricted diet.
Children’s also is the first and only pediatric transplant center in the nation to expand the geographic reach of its program through a partnership with the University of Virginia Children’s Hospital in Charlottesville, Virginia.
|Date of upload: 15th Mar 2017|
Copyright © 2017 MiddleEastHealthMag.com. All Rights Reserved.